AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1996738
Drug: Ivermectin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin (1 mg oral dose)
Trial: 6340972
Drug: Fentiazac 400
RxNorm normalized name: fentiazac
DrugBank: Fentiazac (DB13217)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentiazac 400 mg daily
Trial: 6340972
Drug: Sulindac 200
RxNorm normalized name: sulindac 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac 200 mg daily
Trial: 25245218
Drug: CCRT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCRT with 20 mg/m2 cisplatin for 5 days
Trial: 21848925
Drug: Internet-based blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based blood glucose monitoring system (submitted weekly for 6 months)
Trial: 17440420
Drug: Liberal transfusion
RxNorm normalized name: dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liberal transfusion threshold (10 g/dL hemoglobin)
Trial: 17440420
Drug: Restrictive transfusion
RxNorm normalized name: Pinus spp. wood destructive distillate
DrugBank: Pine tar (DB15840)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive transfusion threshold (7 g/dL hemoglobin)
Trial: 12384647
Drug: L-arginine (L-A)
DrugBank: L-arginine (DB17289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (L-A) infusion at a rate of 1.5 g/min for 20 min
Trial: 9563145
Drug: Dibenyline 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dibenyline 10 mg b.i.d. (n = 71)
Trial: 9563145
Drug: Finasteride 5
RxNorm normalized name: finasteride 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 5 mg q.d. (n = 54)
Trial: 9563145
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dibenyline and finasteride (n = 65)
Trial: 27630504
Drug: Perio Q(TM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perio Q(TM) gel + SRP
Trial: 27630504
Drug: tea tree
RxNorm normalized name: tea tree
DrugBank: Melaleuca alternifolia leaf (DB14372)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tea tree oil gel + SRP
Trial: 27630504
Drug: placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo gel + SRP
Trial: 23249098
Drug: Prednisolone treatment
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone treatment for 32 weeks
Trial: 23249098
Drug: Prednisolone treatment
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone treatment for 20 weeks
Trial: 21041813
Drug: 9 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 g/d oligofructose-enriched inulin in a calcium-fortified cereal
Trial: 9730069
Drug: Oral mucosal
RxNorm normalized name: Finafta Multi Oral Mucosal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mucosal adhesive film containing dibucaine (DC) at a dose of 0.113 mg/cm2
Trial: 9730069
Drug: Oral mucosal
RxNorm normalized name: Finafta Multi Oral Mucosal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mucosal adhesive film containing dibucaine (DC) at a dose of 0.225 mg/cm2
Trial: 12859302
Drug: Dexamethasone 4
RxNorm normalized name: dexamethasone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 4 mg i.v.
Trial: 8137516
Drug: GH-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH-releasing hormone 1 microgram/kg body weight
Trial: 8137516
Drug: GH-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH-releasing hormone without dexamethasone pretreatment
Trial: 2605801
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg of perindopril
Trial: 2605801
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of perindopril
Trial: 2605801
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg of perindopril
Trial: 1159330
Drug: Gentamicin sulfate
RxNorm normalized name: Gentamicin Sulfate
DrugBank: Gentamicin (DB00798)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gentamicin sulfate (1.5 mg/kg) intravenous injection
Trial: 1159330
Drug: Gentamicin sulfate
RxNorm normalized name: Gentamicin Sulfate
DrugBank: Gentamicin (DB00798)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gentamicin sulfate (1.5 mg/kg) intramuscular injection
Trial: 28678332
Drug: Strength group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strength group (oral hypoglycemic medications, subcutaneous insulin infusion, or continuous infusion by micropump)
Trial: 28678332
Drug: Mitigation group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitigation group (personalized treatment programs)
Trial: 11834234
Drug: Leios (0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leios (0.02 mg ethinyl estradiol and 0.1 mg levonorgestrel)
Trial: 11834234
Drug: Stediril 30
RxNorm normalized name: ropivacaine
DrugBank: Ropivacaine (DB00296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stediril 30 (0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel)
Trial: 22840866
Drug: Tamsulosin 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.8 mg
Trial: 3278498
Drug: Indomethacin (25‐50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (25‐50 mg bolus plus infusion, 5‐7.5 mg h‐1) in lactated Ringer solution
Trial: 30573769
Drug: Interactive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive group format treatment (6 sessions, 2 hours each, one session per week)
Trial: 30573769
Drug: Interactive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive group format treatment
Trial: 31347489
Drug: Test canagliflozin
RxNorm normalized name: Canagliflozin
DrugBank: Canagliflozin (DB08907)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Test canagliflozin formulation (100 mg)
Trial: 31347489
Drug: Reference canagliflozin
RxNorm normalized name: Canagliflozin
DrugBank: Canagliflozin (DB08907)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Reference canagliflozin formulation (100 mg)
Trial: 10599729
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment group A, 4 IU/m2 x day
Trial: 10599729
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment group B, first year 4 and thereafter 6 IU/m2 x day
Trial: 10599729
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment group C, first year 4, second year 6, and thereafter 8 IU/m2 x day
Trial: 10599729
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment groups A, B, C
Trial: 10599729
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment group A
Trial: 7657044
Drug: no treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no treatment (control group)
Trial: 1932297
Drug: Ceftazidime with
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftazidime with amikacin (1.5 g/day)
Trial: 6211997
Drug: Althesin infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Althesin infusion
Trial: 12849808
Drug: Unopposed hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unopposed hormone therapy (CEE)
Trial: 12849808
Drug: Opposed hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Opposed hormone therapy (CEE and medroxyprogesterone acetate)
Trial: 8983399
Drug: Epristeride 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epristeride 5 mg oral dose
Trial: 8983399
Drug: Epristeride 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epristeride 4.5 mg intravenous infusion
Trial: 8983399
Drug: Epristeride 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epristeride 5 mg oral dose and 4.5 mg intravenous infusion
Trial: 1750594
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (double-blind, placebo-controlled)
Trial: 1750594
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (open administration)
Trial: 6174719
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron therapy for 6 to 8 days
Trial: 31402114
Drug: Guselkumab (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guselkumab (100 mg at weeks 0 and 4 then every 8 weeks)
Trial: 31402114
Drug: Secukinumab (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab (300 mg at weeks 0, 1, 2, 3, and 4, then every 4 weeks)
Trial: 28674348
Drug: Esomeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole (20 mg) in EAC group
Trial: 28674348
Drug: Rabeprazole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (10 mg) in RAC group
Trial: 24977401
Drug: Sublingual alprazolam
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual alprazolam (0.5 mg)
Trial: 24977401
Drug: Oral alprazolam
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alprazolam (0.5 mg)
Trial: 22545364
Drug: Triamcinolone ointment
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone ointment (twice a day)
Trial: 22545364
Drug: Oral atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral atorvastatin (20 mg daily)
Trial: 22545364
Drug: Placebo atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo atorvastatin tablet (daily)
Trial: 22545364
Drug: Placebo triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo triamcinolone ointment (twice a day)
Trial: 21535498
Drug: White Bread
RxNorm normalized name: White bread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White Bread (WB) 57 g, 160 cal, 1 g fiber
Trial: 21535498
Drug: Raw Cranberries
RxNorm normalized name: raw sugar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raw Cranberries (RC) 55 g, 21 cal, 1 g fiber
Trial: 21535498
Drug: Sweetened Dried
RxNorm normalized name: peptone,dried
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sweetened Dried Cranberries (SDC) 40 g, 138 cal, 2.1 g fiber
Trial: 21535498
Drug: Sweetened Dried
RxNorm normalized name: peptone,dried
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sweetened Dried Cranberries with Less Sugar (SDC‐LS) 40 g, 113 cal, 1.8 g fiber + 10 g polydextrose
Trial: 16051497
Drug: Controlled doses
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled doses of computer work involving prolonged static posture
Trial: 16051497
Drug: Controlled doses
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled doses of computer work involving increased typing speed
Trial: 16051497
Drug: Controlled doses
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled doses of computer work involving increased typing force
Trial: 10076111
Drug: Intradermal injection
RxNorm normalized name: Dryvax Intradermal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal injection of normal saline solution
Trial: 2864073
Drug: Celiprolol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol (0.15 mg/kg/5 min iv)
Trial: 2864073
Drug: Celiprolol (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol (0.3 mg/kg/5 min iv)
Trial: 2864073
Drug: Propranolol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.1 mg/kg/5 min)
Trial: 29384903
Drug: linezolid 600
RxNorm normalized name: linezolid 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: linezolid 600 mg twice daily for 10 days
Trial: 31391682
Drug: Chlorophytum borivilianum
RxNorm normalized name: CHLOROPHYTUM BORIVILIANUM WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorophytum borivilianum (CB) 3 g/day
Trial: 26965722
Drug: Epidural block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural block (group E&G) with continuous epidural and general anaesthesia, using ropivacaine for intraoperative and postoperative blocks.
Trial: 26965722
Drug: General anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anaesthesia only (group G) with remifentanil for analgesia.
Trial: 23673093
Drug: Compliance with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compliance with blood cultures before antibiotics protocol
Trial: 17175635
Drug: Arginine treatment
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine treatment (0.4 g x kg(-1) x d(-1) orally for 7 days)
Trial: 17175635
Drug: Arginine treatment
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine treatment and Placebo
Trial: 10219183
Drug: Preventive oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive oral protocol consisting of elimination of bacterial plaque, mouthwash with chlorhexidine 0.12%, topical application of iodopovidone, and nystatin 500,000 units.
Trial: 10219183
Drug: Palliative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palliative treatment for complications (Group I).
Trial: 3359824
Drug: Bronchoalveolar lavage
RxNorm normalized name: lovage oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchoalveolar lavage with 200 ml of 25 degrees C normal saline solution
Trial: 3359824
Drug: Bronchoalveolar lavage
RxNorm normalized name: lovage oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchoalveolar lavage with 200 ml of 37 degrees C normal saline solution
Trial: 29200983
Drug: PROHIGH (2.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PROHIGH (2.9 g.kg‐1.d‐1)
Trial: 29200983
Drug: PROMOD (1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PROMOD (1.8 g.kg‐1.d‐1)
Trial: 25689594
Drug: PPV/CI guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPV/CI guided group (target PPV <12%, CI >2.5 L/min/m², MAP >70 mmHg)
Trial: 23517178
Drug: Betahistine (48
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betahistine (48 mg)
Trial: 20627917
Drug: Laboratory APAP
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laboratory APAP titration
Trial: 20627917
Drug: Home APAP
RxNorm normalized name: ACETAMINOPHEN 325 mg ORAL TABLET, COATED [Medique at Home APAP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home APAP titration
Trial: 19108595
Drug: Moderate and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate and deep sedation (MAC) using ketamine-midazolam-propofol anesthetic combination
Trial: 16618562
Drug: Tolterodine extended
RxNorm normalized name: tolterodine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine extended release (TER) 4 mg once daily 4 hours or less before bed
Trial: 10782908
Drug: Amoxicillin-clavulanic acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanic acid (1 g-0.2 g every 8 h intravenously, then 500 mg-125 mg every 8 h orally)
Trial: 10782908
Drug: Cefotaxime (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime (1 g every 6 h intravenously)
Trial: 10782908
Drug: Amoxicillin-clavulanic acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanic acid (for patients on prophylactic norfloxacin)
Trial: 768913
Drug: Acebutolol (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (600 mg/day)
Trial: 2870124
Drug: Metoprolol (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (300 mg/day)
Trial: 20199265
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment of femoropopliteal arteries
Trial: 11982840
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (10 microg x kg(‐1)) with 0.5% tetracaine D10 (hyperbaric morphine group)
Trial: 11982840
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine mixed with saline after 0.5% tetracaine D10 (hypobaric morphine group)
Trial: 16490430
Drug: Rosiglitazone monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone monotherapy at 4 mg/day for 3 months
Trial: 16490430
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with rosiglitazone at 4 mg/day and atorvastatin at 10 mg/day for 3 months
Trial: 12969088
Drug: L30AC (twice‐daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L30AC (twice‐daily 30 mg lansoprazole, 1000 mg amoxicillin and 500 mg clarithromycin for 7 days)
Trial: 12969088
Drug: L15AC (twice‐daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L15AC (twice‐daily 15 mg lansoprazole, 1000 mg amoxicillin and 500 mg clarithromycin for 7 days)
Trial: 12969088
Drug: LP (once‐daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LP (once‐daily 15 mg lansoprazole for 14 days)
Trial: 11038044
Drug: LV5FU2 regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LV5FU2 regimen (leucovorin 100 mg/m2 + 5-FU 400 mg/m2 bolus + 5-FU 600 mg/m2 infusion)
Trial: 11038044
Drug: LV5FU2 +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LV5FU2 + CPT-11 regimen (CPT-11 at 180 mg/m2 on day 1 before LV5FU2)
Trial: 3888594
Drug: Intravenous cimetidine
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous cimetidine and pirenzepine (group A)
Trial: 3888594
Drug: Intragastric magnesium-aluminium-hydroxide
RxNorm normalized name: aluminium hydroxide
DrugBank: Aluminum hydroxide (DB06723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intragastric magnesium-aluminium-hydroxide concentrate (antacid, group B)
Trial: 24997616
Drug: Steroid +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid + bupivacaine
Trial: 22992072
Drug: BG-12 (twice-daily,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BG-12 (twice-daily, 240 mg)
Trial: 22992072
Drug: BG-12 (thrice-daily,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BG-12 (thrice-daily, 240 mg)
Trial: 22992072
Drug: BG-12 (twice-daily)
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BG-12 (twice-daily)
Trial: 22992072
Drug: BG-12 (thrice-daily)
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BG-12 (thrice-daily)
Trial: 20808333
Drug: Phytosterol-abundant diet
RxNorm normalized name: phytosterols
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phytosterol-abundant diet (449 mg phytosterols/2000 kcal)
Trial: 20808333
Drug: Phytosterol-poor diet
RxNorm normalized name: phytosterols
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phytosterol-poor diet (126 mg phytosterols/2000 kcal)
Trial: 9925124
Drug: Fructooligosaccharides (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructooligosaccharides (15 g/d)
Trial: 9925124
Drug: Glucose as
RxNorm normalized name: Publix Glucose Assorted Flavors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose as a placebo (4 g/d)
Trial: 7768081
Drug: Combined lipo-PGE1/glucagon-insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined lipo-PGE1/glucagon-insulin therapy (group B)
Trial: 7768081
Drug: Glucagon-insulin therapy
RxNorm normalized name: Glucagon
DrugBank: Glucagon (DB00040)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Glucagon-insulin therapy only (group A)
Trial: 6998537
Drug: Prophylactic co-trimoxazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic co-trimoxazole (single dose)
Trial: 31112457
Drug: 10 session
RxNorm normalized name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [SESSION SAVERS SUNSCREEN BROAD SPECTRUM SPF 30 WATER RESISTANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 session psychiatric standard treatment with added Plan Analysis and Motive Oriented Therapeutic Relationship
Trial: 31112457
Drug: 10 session
RxNorm normalized name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [SESSION SAVERS SUNSCREEN BROAD SPECTRUM SPF 30 WATER RESISTANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 session psychiatric standard treatment without the added Plan Analysis and Motive Oriented Therapeutic Relationship
Trial: 22948339
Drug: Allergen-specific immunotherapy
RxNorm normalized name: Pacific halibut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allergen-specific immunotherapy